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 The evidence base underpinning paediatric palliative care (PPC) needs professional attention 
if advances in practice and reduction in suffering are to be achieved. While current guidance1  
emphasises the need to include children and young people (CYP), both those in good health 
and those with life limiting conditions (LLC) or life threatening illnesses (LTI) in decisions 
about health and health research2, it is commonly accepted that this is not easily achieved in 
practice. Challenges faced by researchers aiming to recruit CYP with LLC or LTI and their 
families are numerous, including small sample sizes and limited funding as well as 
difficulties with ethics committees, the unpredictable nature of the illnesses and society’s 
perceptions of the potential physical and psychological burden for participants and their 
families.  
Research from within the Louis Dundas Centre for Children’s Palliative Care has highlighted 
how attitudes and experiences of working with CYP with LLC or LTI can influence if, when 
and how clinicians introduce the prospect of research participation to families of children 
with LLC or LTI3. Indeed, even when participants are successfully recruited, the lack of 
detailed, standardised reporting of how recruitment was achieved hinders our ability to 
decipher the applicability of research to our own populations of interest.  
In light of these challenges, and to help to pin-point what are seen as the main barriers to 
research in this population, in July 2015 a convenience sample consisting of delegates of the 
7th Paediatric Palliative Care Conference in Cardiff, UK were approached. This conference is 
an important conference in the paediatric palliative care calendar bringing together clinicians, 
researchers and policy makers from around the UK and internationally.  Delegates were 
asked to answer individually and anonymously on a sheet of paper the following question:  
 “In your experience, what have you found to be the biggest barriers to palliative care 
research with children?” 
 The majority of delegates attending the Louis Dundas Centre symposium on the final day of 
the conference, answered our question, n=76 (out of approximately 80 in the room, estimated 
by the Louis Dundas Centre researchers  who handed out and collected the surveys).  The 
international delegates included researchers and a range of health care professionals including 
clinicians, nurses and psychologists working in a variety of settings including hospitals, 
universities and hospices. 
Delegates’ responses were categorised into four themes which were derived from the data: 
time and other resources, clinician’s attitudes towards research, clinician’s perceptions of 
patients and their families, and the ethical approval process (table 1).    
 INSERT TABLE 1 HERE  
Over half of the delegates (43) reported that time and other resources were a barrier to their 
research with CYP with LLC or LTI.  This is perhaps not surprising, given that the majority 
of delegates were clinicians. It is well known that the demands and pressures on paediatric 
palliative care clinicians are heavy and high. This was demonstrated through comments such 
as “Limited resources – lean teams with limited capacity to take on additional work”. What 
this emphasises is the relatively low place of research on paediatric palliative care clinicians’ 
agendas.  
Survey responses pointed to a lack of experience and confidence in conducting research 
amongst participating delegates (“No one in my organisation seems to have any 
interest/desire… to start (a) project”). In addition, many references were made by delegates 
to a paternalistic view of the role of health care professionals (“we can’t burden them and 
their families”).  A fear of “intruding” or “upsetting” families was also commonly reported. 
 The final barrier identified, reported by nearly a third of delegates (n=24) concerned the 
ethical approval processes; this was despite the sample comprising only a small number of 
researchers. Responses revealed that delegates viewed the ethical approval process as 
“arcane”, “challenging” and “restrictive”.  
Despite calls to increase research with CYP with LLC or LTI, the findings from this 
descriptive study suggest that there is still much work to be done before this can be achieved. 
The responses outlined in this survey from professionals working in the field of PPC suggest 
what may often be the key barriers hindering research both at the institutional (ethics 
committees, resources) and individual levels (clinicians’ attitudes towards research and 
potential participants).  
A larger project currently underway at the Louis Dundas Centre for Children’s Palliative 
Care, builds on the findings of this research and current reports in the literature. The project 
includes a nationwide survey of researchers working with children with life limiting 
conditions and life threatening illnesses and their families. Issues  identified here are explored 
in depth with particular attention to; researcher access to participants and ethical approval 
processes. By pooling the knowledge of experts working within the field and drawing from 
their experiences, the study  aims to identify ways to promote and facilitate the development 
of a robust evidence base for paediatric palliative care.  
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Table 1. Summary of barriers to conducting research identified from survey responses 
Barrier Exemplar quotes  Number of delegates 
mentioning barrier (N=76) 
Time and other 
resources 
 
“Lack of protected time or accessible 
funding to develop research projects 
to a fundable stage” 
 
“Lack of protected time or accessible 
funding to develop research projects 
to a fundable stage. Difficulty 
establishing academic-clinical 
partnerships – we’re still in silos!” 
43 
Clinician’s attitudes 
towards research 
“No academic niche – it doesn’t fit 
with my university’s priorities” 
 
“Influencing the research 
agenda/priorities. Influencing 
organisational leaders of the 
importance/value of research in 
practice in voluntary sector – 
building research capacity by 
embedding researchers in 
teams…Small numbers issues – more 
collaboration across teams/areas to 
develop critical mass” 
31 
Clinician’s 
perceptions of 
patients and their 
families 
“Clinician’s willingness to involve 
families in what can be perceived as 
an extra burden. Also time; we know 
some of these families on their 
journey may be short and rushed” 
 
“Concerns re overburdening families 
at a very sensitive time.” 
29 
Ethical approval 
processes 
“Nightmare of ethical approval” 24 
 “Ethics committees who are scared 
of PPC + dying!” 
 
